Yale’s COVID-19 Saliva Test Used In NBA Gets FDA Emergency Approval

The U.S. Food and Drug Administration announced on Saturday that it had granted emergency use authorization for the SalivaDirect test, developed at the Yale School of Public Health. Scientists say it appears to be reasonably accurate, cheap, and fast. Researchers said the analysis could yield results in under three hours, and they expect labs to charge about $10 per sample. The NBA funded the test’s development, and teams give it to asymptomatic players.